EP2100618
And-PDGFR-alfa mótefni til notkunar í meðhöndluninni á meinvarpsbeinkrabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
19.6.2006EP published:
12.2.2014EP application number:
09075102.5
EP translation filed:
24.3.2014Grant published:
15.4.2014EPO information:
European Patent Register
Max expiry date:
18.6.2026Expiry date:
18.6.2020
Title:
An anti-PDGFRalpha antibody for use in the treatment of metastatic bone cancer
Timeline
Today
19.6.2006EP application
12.2.2014EP Publication
24.3.2014Translation submitted
15.4.2014Registration published
18.6.2020Expires
Owner
Name:
ImClone LLCAddress:
450 East 29th Street, 12th Floor, 10016, New York , NY, US
Name:
Philadelphia Health and Education Corporation d/b/a Drexel University College of MedicineAddress:
245 North 15th Street, 19102, Philadelphia, PA, US
Inventor
Name:
Loizos, NickAddress:
Staten Island, NY, US
Name:
Dolloff, Nathan GraemeAddress:
Haverton, Pennsylvania, US
Name:
Fatatis, AlessandroAddress:
Penn ValleyPennsylvania, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
691920 PDate:
17.6.2005Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, A61K 38/17, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 1.4.2014
Expires: 18.6.2015
Payer: Árnason Faktor
Number: 10
Paid: 12.5.2015
Expires: 18.6.2016
Payer: Örn Þór, slf.
Number: 11
Paid: 11.5.2016
Expires: 18.6.2017
Payer: Örn Þór, slf.
Number: 12
Paid: 15.5.2017
Expires: 18.6.2018
Payer: Örn Þór, slf.
Number: 13
Paid: 9.5.2018
Expires: 18.6.2019
Payer: Örn Þór, slf.
Number: 14
Paid: 14.5.2019
Expires: 18.6.2020
Payer: Örn Þór, slf.